Skip to main content
Press
Contact
Global sites
About Us
Corporate Profile
Our Company
Vision
Values
History
Diversity & Inclusion
Transparency
Sustainability
Corporate Citizenship
Press
News
Press Releases
Image Mediapool
Videos
Social Media
Events & Initiatives
Media Contacts
Annual Press Conference
Global Activities
Europe
North America
South America
Asia
Africa
Australasia
Products
Innovation
Research & Development
Research Approach
Therapeutic Areas
Research Beyond Borders
Drug Discovery
Clinical Trials
Overview
Boehringer Ingelheim Venture Fund
Partnering
Our Approach
Overview
What We Offer
Partnering Interests
Overview
How We Engage
Overview
Boehringer Ingelheim Venture Fund
News & Communications
Press Releases
Events
Partnering Newsletter
Contact Us
Prescription Medicine
Cardiovascular
Stroke Prevention
Acute Ischaemic Stroke
DVT/PE
Reversal of Anti-coagulation
Myocardial Infarction
Hypertension
Oncology
Lung Cancer
Respiratory
Asthma
COPD
IPF
SSc-ILD
Central Nervous System
Overview
Metabolic Diseases
Diabetes
IntroDia
Immunology
Overview
Animal Health
Biopharma
Careers
Search form
Search
Our Activities in Oncology
Dr Joerg Barth, Therapeutic Area Head Oncology
